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2Abstract
Breast cancer is the most common invasive neoplasia, and the second leading 
cause of the cancer deaths in women worldwide. Mammary tumorigenesis is 
severely linked to obesity, one potential connection is leptin. Leptin is a hormone 
secreted by adipocytes, which contributes to the progression of breast cancer. Cell 
migration, metalloproteases secretion, and invasion are cellular processes 
associated with various stages of metastasis. These processes are regulated by 
the kinases FAK and Src. In this study, we utilized the breast cancer cell lines 
MCF7 and MDA-MB-231 to determine the effect of leptin on FAK and Src kinases 
activation, cell migration, metalloprotease secretion, and invasion. We found that 
leptin activates FAK and Src, and induces the localization of FAK to the focal 
adhesions. Interestingly, leptin promotes the activation of FAK through a Src and 
STAT3-dependent canonical pathway. Specific inhibitors of FAK, Src and STAT3 
showed that the effect exerted by leptin in cell migration in breast cancer cells is 
dependent on these proteins. Moreover, we established that leptin promotes the 
secretion of the extracellular matrix remodelers, MMP-2 and MMP-9 and invasion 
in a FAK and Src dependent manner. Our findings strongly suggest that leptin 
promotes the development of a more aggressive invasive phenotype in mammary 
cancer cells.
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3Introduction
Breast cancer is the most common invasive neoplasia and the second-leading 
cause of cancer-related death in women worldwide. Over  2,000,000 cases are 
diagnosed annually worldwide, which represents the highest incidence of cancer in 
the world [1]. Also, obesity is a known risk factor for initiation, growth, invasion, and 
metastasis in breast cancer [2]. Metastasis is a complication of cancer in which 
neoplastic cells escape from the primary tumor, and develop secondary tumors in 
distant organs [3]. This process involves loss of cell-cell junctions and cell-
extracellular matrix (ECM) interactions, acquisition of migratory capacity, matrix 
metalloproteases (MMPs) secretion, degradation of ECM and release from the 
basement membrane which leads to cell invasion [3]. Importantly, obese female 
patients present larger and more aggressive metastatic tumors to lymph nodes, 
than non-obese patients [4]. Obesity is characterized by an increase in adipokines 
production, which further enhance the predisposition of developing breast tumors 
[4]. Among these molecules, leptin is one of the most important adipokines 
involved in the development and progression of mammary tumors [5]. 
Leptin is a hormone with a molecular weight of ~16 KDa, encoded by the 
LEP gene located on human chromosome 7 [6]. It is synthesized and secreted 
mainly by adipocytes, and in a smaller proportion, by the placenta, stomach, 
fibroblasts, skeletal muscle, and normal or tumorigenic epithelial mammary tissue 
[7]. One of the primary functions of leptin is the regulation of food intake and 
energy expenditure, acting primarily through the hypothalamus [8]. Leptin also 
regulates reproductive, immunological and metabolic functions [9]. Additionally, 
leptin is involved in the progression of breast cancer, through the activation of 
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4mitogenic, anti-apoptotic and metastatic pathways [2]. Leptin exerts these effects 
through the binding to the ObR receptor, activating various cellular signaling 
cascades such as JAK-STAT, MAPK and PI3K-Akt [7]. Recent evidence showed 
that leptin levels in the plasma are higher in breast cancer patients compared with 
healthy individuals[2,10]. Furthermore, leptin and its ObR receptor are 
overexpressed in primary and metastatic mammary tumor tissues, suggesting an 
autocrine signaling mechanism developed by tumor cells [11].
Importantly, leptin seems to be related to breast cancer risk in 
premenopausal obese women, however controversy exist [12]. For instance, 
epidemiological analyses performed by the World Cancer Research Fund and the 
American Institute for Cancer Research from data up to 2017 showed that being 
overweight or obese decreased the risk of premenopausal breast cancer [12]. 
Meta-analysis analyses of pre-menopausal patients showed a reduced risk per 5 
kg/m2 increase in the body mass index (BMI) [13]. Thus, it was proposed that the 
pathophysiology between obesity and reduced breast cancer risk in pre-
menopause women may be associated on their systemic high levels of estrogens, 
which in turn reduce gonadotrophin release, and decreased progesterone levels, 
thus reducing cell proliferation in mammary glands [14]. Contradictory studies in 
this regard, have proposed that progesterone may be protective against breast 
cancer [14].Studies in various populations have shown modest relationships 
between BMI, obesity and potential to develop breast cancer [15]. On the other 
hand, studies in post-menopausal women showed that obese postmenopausal 
women presented increased risk for breast cancer compared to non-obese 
patients; furthermore and the degree of obesity has been correlated to larger 
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5tumors and metastasis [16]. These patients are characterized by presenting with 
estrogen (ER-) and progesterone receptor (PR)-positive breast cancers, and not to 
ER-negative and triple-negative tumors [16]. Thus, the effect of increased weight 
and BMI, as well as the role of leptin and the potential molecular mechanisms by 
which it contributes to breast cancer progression still remains to be elucidated.
The focal adhesion kinase (FAK) participates in the formation of focal 
adhesions, and activates signaling pathways related to proliferation, survival, cell 
migration, and angiogenesis [17]. Classically, FAK is activated during the formation 
of focal adhesions, and it is mediated by the interaction between ECM with β-
integrins, triggering conformational changes in these receptors [18]. This effect is 
followed by the auto-phosphorylation of FAK at Y397, which creates a high-affinity 
binding site for the Src-homology 2 (SH2) domain of Src, a non-receptor tyrosine 
kinase [19]. Active Src phosphorylates the Y576 and Y577 located at the kinase 
domain of FAK, leading to maximum catalytic activity of FAK, and the formation of 
a transient FAK–Src signaling complex [17]. Cell migration is a key step in 
metastasis of tumor cells, and occurs via two mechanisms: 1) amoeboid, 2) 
mesenchymal patterns [20]. While the amoeboid-type of migration has been 
reported to be independent of integrins and proteases [21], the mesenchymal 
migration is dependent on integrins, proteases and activation of the FAK signaling 
pathway [22]. In addition, FAK and Src have been associated with migration events 
such as MMPs expression, secretion and activation which in turn correlates with a 
highly invasive capacity of tumor cells [23]. In particular, MMP-2 and MMP-9 
degrade type IV collagen and promote the rupture of basal membranes in 
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6colorectal, prostate, lung and breast cancer [24,25]. Importantly, serum samples 
from breast cancer patients, have shown that high levels of MMP-2 and MMP-9 are 
directly associated with metastasis, and further provide evidence of the 
participation of these MMPs in breast cancer progression. Considering these 
evidence, we hypothesized that leptin promotes FAK and Src activation, as well as 
metastasis-associated events such as cell migration, metalloproteases secretion 
and invasion.
In this study, we evaluated the role of leptin in the activation of FAK and Src 
kinases, and their roles in cell migration, metalloproteases secretion, and invasion 
in a cultured cell model of breast cancer. We utilized the breast cancer cell lines 
MCF7 and MDA-MB-231, and found that leptin activates FAK and Src. Using a 
combination of inhibitors for these kinases we found a decrease in metastasis-
associated events such as cell migration, metalloproteases secretion, and invasion 
in breast cancer cells. The data represented here contributes to the molecular 
characterization of the signaling events associated with leptin contributions to cell 
migration and invasion in breast cancer cell lines.
Materials and Methods
Materials
Recombinant human leptin, FAK (PF-573228) and Src (PP2) inhibitors were 
obtained from Sigma-Aldrich (St Louis, MO, USA). The Src (SU6656) and the 
STAT3 inhibitor (S31201) were from Merck (Kenilworth, NJ). Mouse anti-actin, 
rabbit anti-FAK and anti-Src antibodies were purchased from Santa Cruz 
Biotechnology (Santa Cruz, CA, USA). The phospho-specific antibody against 
FAK, rabbit anti-pY397, was obtained from Invitrogen (Carlsbad, CA, USA). The 
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7phospho-specific antibody against Src, rabbit anti-pY418, was obtained from 
MyBiosource (San Diego, CA, USA), species-specific secondary HRP-conjugated 
antibodies were from Millipore (Billerica, MA, USA) and the secondary antibody 
anti-rabbit conjugated with Alexa Fluor 488 was from Invitrogen (Carlsbad, CA, 
USA). Phalloidin coupled to TRITC was purchased from Cytoskeleton (Denver, 
CO, USA).
Cell culture
The breast cancer cell lines MCF7 and MDA-MB-231 (ATCC, Manassas, 
VA, USA) were cultured in DMEM/F12 media (50:50, V:V; Sigma-Aldrich, St Louis, 
MO) supplemented with 5% fetal bovine serum (FBS) and 1% antibiotics (penicillin 
G/Streptomycin, Gibco, Waltham, MA) in a humidified atmosphere containing 5% 
CO2 at 37 0C. For experimental purposes, cell cultures were serum-starved for 24 h 
before treatment with either FAK or Src inhibitors and/or leptin. For experimental 
purposes, cell cultures were used between passages 3 and 15.
Cell stimulation by leptin and kinase inhibitors
MCF7 and MDA-MB-231 cell cultures were seeded in 60 mm plates 
containing 4 ml of DMEM/F12. When the cell cultures reached confluence, they 
were washed with PBS, and then treated with FAK (5 µM, PF-573228), Src (5 µM, 
PP2 and SU6656) or STAT3 (15 and 50 µM) inhibitors, and/or leptin for the times 
indicated in the figure legends. Stimulation of confluent cells was terminated by 
removing the medium, and solubilizing the cells in 0.5 ml of ice-cold radioimmune 
precipitation assay (RIPA) buffer, containing 50 mM HEPES pH 7.4, 150 mM NaCl, 
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81 mM EGTA, 1 mM sodium orthovanadate, 100 mM NaF, 10 mM sodium 
pyrophosphate, 10% glycerol, 1% Triton X-100, 1% sodium deoxycholate, 1.5 mM 
MgCl2, 0.1% SDS and 1 mM phenylmethylsulfonyl fluoride (PMSF, Sigma-Aldrich). 
Western blot
Whole cell lysates (20 µg) were resolved on 10% SDS-polyacrylamide gels. 
Proteins were transferred to nitrocellulose membranes (Bio-Rad, Hercules, CA). 
The anti-actin, anti-pY397, anti-FAK, anti-pY418 and anti-Src primary antibodies 
were incubated overnight at 4 oC, in agitation at a 1:1,000 dilution. Species specific 
secondary HRP-conjugated antibodies (1:5,000) were incubated for 2 h at room 
temperature. Membranes were developed using an enhanced chemiluminescence 
detection system from Bio-Rad. 
Immunofluorescence 
MCF7 and MDA-MB-231 cells were seeded on glass coverslips, grown to 
70% confluence, and stimulated with or without leptin for 0, 15, 60 and 120 min. 
Cells were fixed for 5 min with 4% paraformaldehyde in PBS and permeabilized 
with 0.2% Triton-X100 in PBS at room temperature. For immunofluorescence (IF) 
assays, the cells were blocked with 3% albumin in PBS for 1 h at room 
temperature. Then, the cells were incubated 2 h at room temperature with the 
rabbit anti-pY397 antibody (1:250 dilution), followed by a 2 h incubation at room 
temperature with an anti-rabbit conjugated to Alexa Fluor 488 secondary antibody 
(1:800 dilution). For F-actin staining, cells were incubated with TRITC-Phalloidin 
(1:500 dilution) for 30 min at room temperature. Cells were counterstained with 
4´6-diamidino-2-phenylindole (DAPI), mounted with Fluoroshield/DAPI media 
Page 8 of 41Accepted Manuscript published as EC-19-0442. Accepted for publication: 31-Oct-2019
Copyright © 2019 the authors Downloaded from Bioscientifica.com at 11/12/2019 07:24:31PM
via University of Massachusetts
9(Sigma-Aldrich), and imaged with an Olympus BX43 microscope, using the 100x 
immersion objective.
Wound healing assays
MCF7 and MDA-MB-231 cells were grown until confluence on 60-mm 
culture dishes supplemented with DMEM/F12 as described above. Cells were 
starved for 24 h in DMEM/F12 without FBS, and treated for 2 h with Cytosine ß-D-
Arabinofuranoside (AraC) to inhibit cell proliferation during the experiment. After 
starvation, cells were scratch-wounded using a sterile 200 μl pipette tip, suspended 
cells were removed by washing with PBS twice, and the cultures were re-fed with 
DMEM/F12 in the presence or absence of the FAK and Src inhibitors, and/or leptin 
as indicated in the figures. The progress of cell migration into the wound was 
monitored at 0 and 48 h using an Olympus BX43 microscope with a 10x objective. 
The bottom of the plate was marked for reference, and the same field of the 
monolayers were photographed immediately after performing the wound (time = 0 
h) and 48 h after treatments (time = 48 h), five images per plate were analyzed. 
The distance between the edges of the wound was measured at time 0 and 48 h, 
and the reported migrated distance corresponds to the difference between these 
two. The migration area was determined by measuring the total area of the wound 
using the ImageJ software and the MRI wound healing tool [26]. 
Gelatin zymography
Cells were stimulated with leptin and the kinases inhibitors as described 
above, the conditioned medium was collected, and concentrated using a 30 kDa 
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cut-off ultra-centrifugal filter units (Amicon, Merck-Millipore, MA). Protein was 
determined by Bradford [27], and 20 µg of protein from concentrated supernatant 
were assayed for proteolytic activity on native gelatin-substrate gels [28]. Briefly, 
samples were mixed with non-reducing buffer containing 2.5% SDS, 1% sucrose 
and 4 mg/ml phenol red, and separated in 8% acrylamide gels co-polymerized with 
1 mg/ml gelatin, as previously described [29]. After electrophoresis at 72 V for 2.5 
h, the gels were rinsed twice in 2.5% Triton X-100, and then incubated in 50 mM 
Tris–HCl pH 7.4 and 5 mM CaCl2 assay buffer at 37 oC for 24 h. Gels were fixed 
and stained with 0.25% Coomassie Brilliant Blue G-250 in 10% acetic acid and 
30% methanol. Proteolytic activity was detected as clear bands against the 
background stain of undigested substrate in the gel. Quantification was performed 
using ImageJ software [26].
Cell Invasion assays
Matrigel invasion assays were performed following the trans-well chamber 
method [30], using 24 well plates containing inserts of 8 mm pore size (Corning 
Inc, Kennebunk, ME). Briefly, 30 µl of Matrigel (Corning) was added into the inserts 
and kept at 37 oC for 30 min to form a semisolid matrix. Control and cells treated 
with the FAK or Src inhibitors were plated at 1X105 cells per insert in serum-free 
medium on the top chamber. The lower chamber of the trans-well contained 600 µl 
DMEM supplemented or not with 100 ng/ml leptin. Cells were incubated for 48 h at 
37 oC in a 5% CO2 atmosphere. Following incubation, cells and Matrigel on the 
upper surface of the trans-well membrane were gently removed with cotton swabs. 
Invading cells on the lower surface of the membrane were washed and fixed with 
methanol for 5 min, and stained with 0.1% crystal violet in PBS. Cell quantification 
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was performed using a hemocytometer and an Olympus BX43 microscope with the 
100X objective. 
Statistical analysis 
Results are expressed as mean ± SD. Data was statistically analyzed using 
one-way ANOVA and the pairwise comparisons were performed using Newman-
Keuls and Dunnett´s multiple comparison test. Statistical probability of P < 0.05 
was considered significant.
Results
Leptin induces FAK activation through the kinase Src in breast cancer cells
FAK activation is triggered by the auto-phosphorylation of Y397, which is an 
indicative of its catalytic activity [22,31]. This process has been associated with 
cancer progression and metastasis-related events [31]. First, we performed time-
course assays to establish whether leptin induces FAK phosphorylation and 
activation in MDA-MB-231 and MCF7 breast cancer cell lines. We found that MDA-
MB-231 cells treated with 100 ng/ml of leptin present a significant increase in FAK 
phosphorylation on Y397, after 10 min of treatment and peaked after 15 min 
compared to the non-treated control cells (Fig. 1A, B). Leptin also activates FAK in 
MCF7 cells, as Y397 phosphorylation is triggered after 15 min of treatment, 
reaching a maximum phosphorylation peak at 30 min (Fig. 1A, C). These data 
indicates that leptin-induced phosphorylation at Y397 occurs shortly after the 
stimulus, but is not sustained for long periods in both breast cancer cell lines. 
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FAK activation is associated to the formation of focal adhesions and cell 
migration, as it contributes to the weakening of cell-cell adhesion and the cyclic 
assembly-disassembly of focal adhesions [32]. Therefore, we analyzed the effect 
of leptin in the subcellular localization of phosphorylated FAK at Y397, and whether 
its activation would promote the formation of stress fibers in MDA-MB-231 and 
MCF7 cells. Cells were incubated with leptin for 15, 30 and 60 min and formation of 
stress fibers was monitored by confocal microscopy. Optical planes taken in 
proximity of the cells with the substrate showed that under normal conditions, the 
MDA-MB-231 cells expressed activated FAK at the periphery of the cells, which 
increased upon leptin stimulus (Fig. 1D, in green). In these cells, the cytosolic actin 
filaments were also abundant, and also increased upon the treatment of leptin (Fig. 
1D, in red). Interestingly, the effect of leptin in FAK activation, and formation of 
stress fibers was more evident in MCF7 cells. Fluorescense microscopy analyses 
of MCF7 cells showed low levels of activated FAK at the periphery of untreated 
cells (Fig. 1D, in green), which increased throughout the treatment with leptin. 
Importantly, these cells also had increased formation of stress fibers upon leptin 
stimulation (Fig. 1D, in red). Quantification of the fluorescent signal for FAK 
localization at focal adhesions confirmed the increase of this kinase at these 
regions (Fig. 1E). These results suggest that leptin promotes the phosphorylation 
of FAK at Y397, and induces the formation of focal adhesions enriched with stress 
fibers. 
The classic mechanism for FAK activation occurs through auto-
phosphorylation at the Y397 creates a high-affinity binding site for Src [22,33]. The 
interaction between Src and FAK leads to the phosphorylation and activation of Src 
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at Y419, which further result in the phosphorylation of FAK at Y576 and Y577 [22]. 
Src is a tyrosine kinase involved in cell migration and invasion in different triple 
negative cancer cell lines [34]. Therefore, we asked whether leptin also played a 
role in the activation of Src, using the highly invasive triple negative cell line MDA-
MB-231 as an in vitro model. Figure 1F shows that leptin induces Src 
phosphorylation at Y418 in a time-dependent manner, beginning after 10 min of 
stimulation and is sustained for at least 1 h. Quantification of phosphorylated Src at 
Y418 further confirmed the activation of this kinase by leptin (Fig. 1G). Then, we 
asked whether Src was involved on the leptin-induced activation of FAK in both 
cancer cell lines. To explore this possibility we inhibited Src with the specific 
inhibitors PP2 (Fig. 2A-E) and SU5566 (Fig. 2F-J). Western blot analysis and 
quantification showed that Src inhibition in fact decreases FAK activation 
dependent on leptin in both cancer cell lines. Western blot analyses of 
phosphorylated Src at Y418 showed that the kinase was efficiently inactivated by 
the chemical inhibitors (Fig. 2A,D,E). The data is in agreement with previous 
reports of FAK requirement to promote cell migration in MDA-MB-231 and MDA-
MB-468 in breast cancer cell lines [35], and with the effect of FAK auto-
phosphorylation at Y397 in cell migration, invasion, and proliferation of gastric 
carcinomas [36].  
Leptin promotes cell migration in a FAK/Src-dependent manner and the 
STAT3 canonical signaling pathway of the leptin receptor in triple negative 
breast cancer cell line
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The increased expression of phosphorylated Y397 FAK at focal adhesion 
points of MDA-MB-231 and MCF7 cells (Fig. 1) is consistent with the requirement 
for the cycling of focal adhesions during cell migration [37]. These observations 
prompted us to investigate whether FAK was part of the effect of leptin in the 
migration of these cancer cell lines. Figure 3 shows representative light 
microscopy images of MDA-MB-231 and MCF7 cells subjected to wound healing 
assays. The data presented at time 0 h are images of the wounds produced at the 
moment of scratching, and then 48 h after performing the wound depicts the 
migration of both cell lines. Morphological changes were observed at the front edge 
of the wound of both cell lines treated with leptin. Leptin induced a mesenchymal 
phenotype, while the leptin-treated cells cultured with the specific inhibitors of FAK 
(PF-573228, Fig. 3A, C) and Src (SU6656, Fig. 3E) presented an epithelial 
phenotype. Quantification of cell migration for both cell lines showed that cells 
treated with leptin migrated significantly faster than non-treated control cells (Fig. 
3B, D, F). However, in the leptin-stimulated MDA-MB-231 cell line (Fig. 2A, B) 
presented enhanced migration capabilities, compared to MCF7 cells (Fig 3A, C). 
Moreover, the MDA-MB-231 cells pre-treated with either FAK or Src inhibitors plus 
leptin, showed a significant decrease in cell migration compared to the leptin-
treated cells (Fig. 3A,B,E,F). A similar phenotype was observed in MCF7 cells 
treated with the FAK inhibitor PF-573228, however these cells migrated less 
compared to MDA-MB-231 (Fig 3C,D). MCF7 cells presented approximately a 30% 
decrease in the leptin-induced migration properties when treated with the chemical 
inhibitor of FAK, compared to the leptin treated cells (Fig. 3A-D). These results 
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suggest that leptin-induced migration is dependent on the activation of FAK and 
Src signaling pathways in both cancer cell lines. 
Then, we investigated whether the effects of leptin on FAK and Src 
activation and the enhanced migratory capabilities of cultured cancer cells were 
mediated by the canonical leptin-receptor signaling pathway. To this end, we 
focused on the signal transducer and activator of transcription 3 (STAT3), a 
transcription factor which is activated upon leptin binding to its receptor [7]. STAT3 
is overexpressed and constitutively activated in triple negative breast cancer cells, 
and contributes to a wide variety of cellular processes involved in cancer 
progression [38]. Experiments using S31201, the specific inhibitor for STAT3, 
showed that the leptin-dependent phosphorylation of FAK at Y397 is different 
between the two cell lines. MDA-MB-231 cells presented higher levels of FAK 
phosphorylated at the Y437 residue (Fig. 4A,B), while in MCF7 cells this 
phosphorylation was significantly reduced compared to control cells (Fig. 4A,C). 
Surprisingly, the higher level of FAK activation upon STAT3 inhibition did not 
correlated with the enhanced migratory capabilities of these cancer cells observed 
before (Fig. 3). In this case, the MDA-MB-231 cells treated with leptin and the 
STAT3 inhibitor, S3I201, presented a significant decrease wound closure 
compared to leptin-treated cells (Fig. 4D,E). This data suggest that FAK activation 
is not related to STAT3 signaling pathway, supporting the hypothesis that two 
independent mechanisms for signal transduction are activated upon leptin 
stimulation. 
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Leptin increased metalloprotease-2 and -9 secretion and activation in breast 
cancer cells
During migration, the cells need to modify the composition of the ECM by 
secreting MMPs. MMPs are secreted in response to growth factors, hormones, and 
cytokines [39]. To be active, the MMPs bind to divalent cations, such as Zn2+ [40]. 
MMPs are required for cell migration, wound healing, tissue remodeling, and 
angiogenesis among other processes, features by which MMPs are highly relevant 
in diseases such as arthritis and cancer [41]. Metalloproteases secretion, in 
particular MMP-2 and MMP-9, is linked to invasive and metastatic properties of 
cancers cells [42]. Therefore, we asked whether leptin induces the secretion and 
activation of MMP-2 and MMP-9. To test this hypothesis, MDA-MB-231 (Fig. 5A-C) 
and MCF7 cells (Fig. 5G-I) were stimulated with increasing concentrations of leptin 
for 24 h. The supernatants were collected, concentrated and analyzed by gelatin 
zymograms to determine the activity of both MMPs. Figure 5 shows that leptin 
induced a gradual increase in MMP-2 and MMP-9 secretion and activation, which 
co-related with the amount of leptin supplemented into the culture media. In both 
cancer cell lines, a significant increase in the activity of MMP-2 and MMP-9 was 
observed. In the case of MDA-MB-231 cells, the major change in activation of 
MMP-2 occurred at 100 ng/ml of leptin, while the activity of MMP-9 was 
significantly higher at 50 ng/ml compared with the non-treated controls (Fig. 5D-F). 
In the case of MCF7 cells, the activity of MMP-2 was significantly higher at 200 
ng/ml of leptin, and for MMP-9 was at 100 ng/ml of the hormone (Fig. 5G-I). Both 
MMPs reached a maximum peak of activation at 400 ng/ml in both cell lines. 
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To determine the time frame for secretion and activation of the 
metalloproteases induced by leptin, we collected supernatants of MDA-MB-231 
cells stimulated with 100 ng/ml of leptin for 6, 12, 24 and 48 h and assayed for 
gelatinase activity. Figure 5G-I show that leptin induces an increase in both, MMP-
2 and MMP-9 secretion after 6 h, reaching a maximum activity peak at 48 h. 
Together, our data suggest that MMP-2 and MMP-9, two relevant proteins for cell 
migration and metastatic processes, may be induced and activated by the 
exposure of chronic and increasing doses of leptin. Secretion and activated of 
these two MMPs may have a direct co-relation with the enhanced mobility 
capabilities of these cells observed in our wound healing assays (Fig. 3). 
Leptin promotes invasion and secretion of metalloproteases in a FAK/Src-
dependent manner in MDA-MB-231 cells 
Metalloproteases secretion is directly related with invasive capacity of tumor 
cells [43], and might be one of the multiple mechanisms by which FAK positively 
regulates cell migration [22]. If MMP-2 and MMP-9 participate in leptin-dependent 
migration via FAK activation, their secretion must be controlled by a similar 
signaling pathway that controls migration of cancer cells. To test this hypothesis, 
we used the PF-573228 to inhibit FAK signaling pathway and evaluated the effect 
FAK inactivation on the leptin-induced secretion and activation of MMP-2 and 
MMP-9. MDA-MB-231 cells were pre-treated with the FAK inhibitor. Then the cells 
were stimulated with 50 ng/ml of leptin, the supernatants were collected, and 
concentrated for zymogram analyses. We found that pre-treatment with PF-573228 
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significantly inhibited MMP-2 (Fig. 6A,B), and MMP-9 (Fig. 6A,C) secretion and 
activation, when compared to the leptin treated cells.
Further, we tested the role of FAK in the invasiveness capabilities of MDA-
MB-231 cells stimulated with leptin. Cell invasion assay allows the evaluation of the 
intrusive potential of tumor cells through the extracellular matrix, which is directly 
related to processes related to tumor progression and metastasis [44]. Therefore, 
we sought to investigate whether the cancer cells were able to penetrate a model 
barrier consisting of components of the basement membrane in response to leptin 
and FAK inhibition. To this end, the cells were seeded in matrigel-coated Transwell 
chambers in the presence or absence of 100 ng/ml leptin for 48 h. Figure 7A 
shows representative light microscopy images of MDA-MB-231 cultured in the 
presence and absence of leptin, where the hormone promoted an increase in cell 
invasion, as shown by the presence of darker cells characteristic of cell invasion. 
Also, we observed that invasiveness is a FAK-dependent process, as the cells 
treated with 5 μM of PF-573228, showed a decrease in invasiveness properties, 
compared to cells treated with leptin (Fig. 6D, E). These data is consistent with the 
contribution of FAK to the highly invasive phenotype of the triple-negative MDA-
MB-231 and BT549 cancer cells [35,45].
Finally, we evaluated the role of Src in the secretion and activation of 
metalloproteases in MDA-MB-231 cells. We observed that leptin promotes the 
secretion of MMP-2 (Fig. 8A,B) and MMP-9 (Fig. 8A,C) through the activation of 
Src, since culturing the cells with the specific inhibitor of this kinase, PP2, 
prevented this process. This phenotype was accompanied by a decrease in the 
leptin-induced invasive capabilities of the MDA-MB-231 cell line treated with PP2 
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(Fig. 8D,E), supporting the role for Src in cell migration and invasion of cancer 
cells.
Taken together, our data suggest that leptin activates FAK and Src signaling 
pathways in a mechanism that is independent to the classic leptin receptor 
pathway. FaK and Src contributes to the activation and secretion of MMP-2 and 
MMP-9, which in turn drive the cell migration and invasion phenotypes observed in 
in vitro models of mammary cancer cells. This leptin-dependent phenotype 
associated to the activation of FAK and Src is consistent with the aggressive 
phenotype of the tumorigenic and metastatic cancer cells. 
Discussion
Obesity is considered one of the risk factors associated with the 
development and progression of breast cancer [5,46]. Adipose tissue is 
characterized by an increased synthesis of different adipokines such as leptin [7]. 
Leptin regulates several physiological functions such as food intake and energy 
expenditure [8]. However, in vitro studies demonstrated that leptin also induces the 
epithelial-mesenchymal transition (EMT), cell migration and MMPs are secreted in 
the tumor microenvironment in breast epithelial cells [47,48]Thus leptin is 
associated with breast cancer progression [7].  
In this study, we used the non-invasive MCF7 breast cancer cell line, and 
the triple negative highly invasive MDA-MB-231 to investigate the signaling 
pathways underlying cell migration and invasion. Our results showed that leptin 
promotes the phosphorylation and consequent activation of FAK at Y397, in both 
cell lines; however, the phenotypes observed in the triple negative MDA-MB-231 
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were greater than those observed in the MCF7 cells. We observed that in both cell 
lines, leptin activates FAK and Src within 10-15 min of stimulation. Data from the 
colon cancer cell line SW480 reported by Ratke et al. 2010, showed that leptin also 
induces FAK activation in a time-specific manner with a maximal activation at 15 
min, which is consistent with our studies. Although the exact mechanism of leptin-
induced FAK activation has not been described, experimental evidence showed 
that its canonical activation pathway is through the auto-phosphorylation of Y397 
[49], which is in agreement with our observations. This process is a response to 
the binding of integrins to ECM during the formation of focal adhesions [17]. 
However, this might not be the only pathway for FAK activation. It has been 
reported that receptors with tyrosine kinase activity may promote FAK activation in 
NIH 3T3 fibroblastic cell lines [50]. Consistently, in our study FAK phosphorylated 
at Y397 is localized primarily in focal adhesions bound to stress fibers in both 
breast cancer cell lines, which suggest that this subcellular localization is regulating 
cell migration. Interestingly, the activation of FAK/Src seems to be independent of 
the canonical leptin signaling pathway, as inhibition of STAT3, a downstream 
effector of the ObR, did not prevented the activation of these kinases, but reduced 
the migratory capabilities of the cells.    
We evaluated the effect of FAK and Src on leptin-induced cell migration by 
using the chemical inhibitor PF-573228, and PP2 and SU6656. We found that 
leptin promotes migration of breast cancer cells in a FAK/Src-dependent manner. 
Focal adhesions are specialized structures where integrin receptors interact with 
the ECM, and with the actin cytoskeleton to promote cell migration [51]. In addition 
to regulating the formation of focal adhesions, FAK signaling also affects the 
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remodeling of the actin cytoskeleton by inducing the activation of small GTPases 
such as Rho, Rac and Cdc42 [52]. These are associated to the reorganization of 
the actin cytoskeleton by generating structures involved in cell migration, such as 
lamellipodia, filopodia and stress fibers [53]. 
An important feature of tumor progression in cancer cells is the increased 
secretion and activation of metalloproteases [54]. We focused our studies in MMP-
2 and MMP-9 because they are related to invasive and metastatic processes, and 
a highly invasive capacity of tumor cells [23]. Our data showed that in two breast 
cancer cellular models, leptin induces an increase in MMPs secretion and 
activation in a time and dose response-dependent manner. These findings are in 
agreement with evidence collected from serum samples from breast cancer 
patients, where high levels of MMP-2 and MMP-9 is directly associated with 
metastasis, and further provide evidence of the signaling mechanisms [55]. MMP-2 
and MMP-9 expression is connected with different phases of metastasis, such as 
the pre-metastatic niche formation, formation of new blood vessels and local 
invasion [56]. Furthermore, leptin promoted MMP-2 and MMP-9 and cell invasion 
of the triple negative MDA-MB-231 cell line in a FAK/Src-dependent manner. FAK-
dependent induction of MMPs is not limited to cancer; in tenocytes the mechano-
growth factor promotes MMP-2 secretion and cell invasion in a manner dependent 
on FAK and ERK kinases [57]. MMP-9-dependent degradation of fibronectin also 
stimulates cell migration, and invasion of MCF-7 cells in a FAK/Src-dependent 
manner [58]. The relevance of FAK/Src in cell migration and invasive processes 
extends to other cellular systems. For instance, the cell adhesion protein Spondin 1 
also promotes cell migration and invasion through FAK and Src activation in 
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human osteosarcoma cell lines [59], and Src is well known to be increase cell 
permeability, EMT, migration, invasion and metastasis of tumor cells [60]. Our data 
strongly suggest that leptin is associated with the establishment of a more 
aggressive phenotype of the tumor cells promoting local invasion and eventually 
metastasis of tumor cells (Fig. 8).
Conclusion
Taken together, our results demonstrate that leptin promotes cell migration, 
metalloprotease secretion and invasion in a FAK and Src-dependent manner, 
which is independent of the classic leptin route. These events partially explain the 
association between obesity and the development and progression of breast 
cancer and suggest that kinases FAK and Src are central molecules, regulating 
events that favor the metastasis of tumor cells stimulated with leptin, promoting 
changes to a more aggressive phenotype in breast cancer cells.
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Figure Legends
Figure 1. Activation and subcellular localization of FAK in leptin-stimulated breast cancer 
cell lines. (A) MDA-MB-231 and MCF7 cells were treated with 100 ng/ml and 400 ng/ml of leptin, 
respectively, for different times and cultures were lysed. Representative western blots showing 
phosphorylated Y397 FAK and total FAK were detected using specific antibodies. The plots 
represent the densitometric and statistical analysis of the bands obtained by western blot for MDA-
MB-231 (B) and MCF7 (C); the values are the mean ± SD of at least three independent experiments 
and are expressed as changes with respect to the control (unstimulated cells). Asterisks denote 
comparisons made to unstimulated cells. *P < 0.05, **P < 0.01 by one-way ANOVA (Dunnett test). 
(D)  Representative fluorescence microscopy images of MDA-MB-231 and MCF7 treated with or 
without 100 ng/ml leptin and 400 ng/ml at different time points. Anti-pY397 FAK staining is in green, 
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TRITC-phalloidin is shown in red and DNA is stained with DAPI. Arrows indicate focal adhesions. 
(E) Quantification and statistical analyses of fluorescent signal of pY397 and stress fiber formation 
from fluorescence images obtained from MDA-MB-231 and MCF7. Asterisks denote comparisons 
made to unstimulated cells. *P < 0.05, **P < 0.01, ***P<0.001 by one-way ANOVA (Dunnett test). 
(F) Representative Western blot of MDA-MB-231 cells treated with 100 ng/ml leptin at different time 
points. Phosphorylated Src was detected using an anti-pY418 as well as total Src. (G) 
Densitometric and statistical analysis of three independent Western blot analyses of phosphorylated 
Src at pY418. Data represents the mean ± SD, and are expressed as changes with respect to the 
un-treated control. Statistical significance was established at ***P < 0.001 by Dunnett test.
Figure 2. Leptin-induced FAK activation occurs in a Src-dependent manner in MDA-MB-231 
and MCF7 breast cancer cells. (A) Representative western blot of FAK activation at Y397 in the 
presence or absence of 100 and 200 ng/ml leptin and 5 μM of the Src inhibitor SU6656 in MDA-MB-
231 and MCF7 cells. Plots represent the densitometric statistical analyses for each cell type for FAK 
phosphorylation (B,C), and Src (D,E), respectively. (F) Representative western blot of FAK 
activation at Y397 in the presence or absence of 100 ng/ml leptin and 5 μM of the Src inhibitor PP2 
in MDA-MB-231 cells. Plots represent the densitometric statistical analyses for each cell type for 
FAK phosphorylation (G), and Src (h). Antibody against total FAK was used as loading control.
Figure 3. FAK/Src are required for migration of leptin-stimulated MDA-MB-231 and MCF7 
breast cancer cells. Confluent monolayers of MDA-MB-231 cells were treated for 2 h with AraC to 
inhibit proliferation, and then pre-treated with 5 µM of the FAK inhibitor, PF-57322, or with 5 µM of 
the Src inhibitor, PP2, for 30 min. Wound healing assays were performed by scratching the 
monolayer using a sterile pipette tip. Cells were washed and re-fed with DMEM supplemented with 
or without leptin. The progress of cell migration into the wound was registered at 0 (upper panel) 
and 48 h (lower panel). Representative light microscopy images and quantification of wounding 
assays in MDA-MB-231 (A,B) and MCF7 (C,D) breast cancer cell lines and effect of FAK inhibition 
in the wound closure. (E) Representative light microscopy images and quantification of wounding 
assays in MDA-MB-231 by using SU6656, an Src inhibitor (F) and quantification of the wound 
closure and the effect of Src inhibition. Data are expressed as percentage of wound closure for 
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each condition and represents the mean of three independent experiments ± SD. The Newman-
Keuls test compares all experimental conditions to determine statistically significant differences; **P 
< 0.01 by one-way ANOVA.
Figure 4. Leptin promotes cell migration and FAK activation independently of the canonical 
leptin receptor in a model for triple negative breast cancer cells. (A) Representative western 
blot of FAK activation at Y397 in the presence or absence of 100 ng/ml and 200 ng/ml leptin and 50 
and 15 μM of the STAT3 inhibitor S3I201 in MDA-MB-231 and MCF7 cells. Plots represent the 
densitometric statistical analyses for FAK phosphorylation in MDA-MB-231 (B), and MCF7 cells (C). 
Confluent monolayers of MDA-MB-231 cells were treated for 2 h with AraC to inhibit proliferation, 
and then pre-treated with 50 µM of the STAT3 inhibitor, S3I201 for 24 h. Wound healing assays 
were performed by scratching the monolayer using a sterile pipette tip. Cells were washed and re-
fed with DMEM supplemented with or without leptin. The progress of cell migration into the wound 
was registered at 0 (upper panel) and 48 h (lower panel). (D) Representative light microscopy 
images and (E) quantification of wounding assays in MDA-MB-231 breast cancer cells and effect of 
STAT inhibition in the wound closure. Data is expressed as percentage of wound closure for each 
condition and represents the mean of three independent experiments ± SD. The Newman-Keuls 
test compares all experimental conditions to determine statistically significant differences; ***P 
<0.001 by one-way ANOVA.
Figure 5. Leptin promotes the secretion of MMP-2 and MMP-9 in the MDA-MB-231 and MCF7 
cancer cell lines. (A) Representative zymogram of the gelatinase activity of secreted MMP-2 and 
MMP-9 obtained from supernatants of MDA-MB-231 cells stimulated with increasing concentrations 
of leptin for 24 h. Quantification of the gelatinase activity of both secreted metalloproteases MMP-2 
(B), MMP-9 (C) under each experimental condition. (D) Representative zymogram of the gelatinase 
activity of secreted MMP-2 and MMP-9 obtained from supernatants of MCF7 cells stimulated with 
increasing concentrations of leptin for 24 h. Quantification of the gelatinase activity of both secreted 
metalloproteases MMP-2 (E), MMP-9 (F) under each experimental condition. (G) Representative 
zymogram of the gelatinase activity of secreted MMP-2 and MMP-9 obtained from supernatants of 
MDA-MB-231 cells chronically stimulated with 100 ng/ml of leptin. Quantification of the gelatinase 
activity of both secreted metalloproteases MMP-2 (H), MMP-9 (I) under each experimental 
condition. Supernatant samples were collected at the indicated time points. Actin was used as 
loading control in all cases. Data represents the mean of three independent biological experiments 
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± SD and it is expressed as fold increase over the un-treated control. Statistical significance was 
established at *P < 0.05, **P < 0.01, ***P<0.001 by Dunnett test.
Figure 6. Leptin promotes secretion of metalloproteases and increases an invasive 
phenotype of MDA-MB-231 cell line in a FAK-dependent manner. MDA-MB-231 cells were pre-
treated for 30 min with 5 μM of the FAK-specific inhibitor, PF-573228. Then, the cells were 
stimulated without or with 100 ng/ml leptin for 24 h. (A) Representative zymogram of the gelatinase 
activity of MMP-2 and MMP-9 obtained from MDA-MB-231 cells supernatants, actin was used as 
loading control. Quantification of the activity of secreted MMP-2 (B) and MMP-9 (C) for each 
experimental condition, and it is expressed as fold increase over the un-treated control. Statistical 
significance was established at *P < 0.05, **P < 0.01, ***P<0.001 by Dunnett test. (D) 
Representative light microscopy images of invasion assays for MDA-MB-231 cells. The cells were 
pre-treated with 5 μM PF-573228 and seeded at 1x105 cells in Matrigel-coated chambers in the 
presence or absence of 100 ng/ml leptin for 48 h. (E) Cell invasion quantification represents the 
number of invading cells for each experimental condition. Data represents the mean ± SD, and it is 
expressed as fold increase over the un-treated control. Statistical significance was established at *P 
< 0.05, **P < 0.01, by one-way ANOVA (Newman-Keuls test).
Figure 7. Leptin-induced secretion, activation of MMP-2 and MMP-9 and invasion in MDA-MB-
231 cells is Src-dependent. (A) Representative zymogram MMP-2 and MMP-9 obtained from 
supernatants of MDA-MB-231 cells treated with 5 μM of the Src-specific inhibitor, PP2, and 
supplemented with or without 100 ng/ml leptin for 24 h. Quantification of the activity of secreted 
MMP-2 (B) and MMP-9 (C) for each experimental condition, and it is expressed as fold increase 
over the un-treated control. Statistical significance was established at P < 0.05, **P < 0.01, by one-
way ANOVA (Newman-Keuls test). (D) Representative light microscopy images of invasion assays 
for MDA-MB-231 cells. The cells were pre-treated with 5 μM of PP2 and seeded at 1x105 cells in 
Matrigel-coated chambers in the presence or absence of 100 ng/ml leptin for 48 h. (E) Cell invasion 
quantification represents the number of invading cells for each experimental condition. Data 
represents the mean ± SD, and it is expressed as fold increase over the un-treated control. 
Statistical significance was established at *P < 0.05, **P < 0.01, by one-way ANOVA (Newman-
Keuls test).
Figure 8. Representative model of the MMP-2 and MMP-9 secretion induced by leptin in a 
cultured model for breast cancer. Leptin-dependent activation of FAK occurs via Src and an 
independent mechanism from the canonical ObR pathway. These kinases promote the secretion of 
MMPs, cell migration and invasion in cultured models for breast cancer cells.
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